We bridge the gap from simple, high-throughput monocultures to advanced, multi-cellular 3D microfluidic organ-on-chip platforms, providing a seamless pathway to evaluate your candidates in highly physiological microenvironmental conditions.
Creative Biolabs offers specialized in vitro macrophage modeling and evaluation services designed to replicate dynamic tissue microenvironments for preclinical research. We deliver customizable cellular platforms, high-resolution functional assays, and cross-species benchmarking tools to evaluate candidate compounds. By partnering with us, research teams can expect to gain deep biological insights, optimize compound selection, and secure reliable, high-quality data packages. This robust scientific support accelerates early-stage discovery and development programs, allowing sponsors to make confident pipeline decisions without relying on complex, low-throughput in vivo models.
Fig.1 Macrophage phenotypes. 1
Preclinical development is often slowed by the extreme plasticity and complex tissue ontogeny of the human mononuclear phagocyte system. Modern scientific research establishes that macrophages act as critical gatekeepers across oncological, fibrotic, and cardiovascular cellular environments. Consequently, high-fidelity disease modeling is essential for successful translation. Creative Biolabs’s macrophage modeling platforms leverage these physiological insights, offering the research confidence needed to advance downstream development successfully.
We bridge the gap from simple, high-throughput monocultures to advanced, multi-cellular 3D microfluidic organ-on-chip platforms, providing a seamless pathway to evaluate your candidates in highly physiological microenvironmental conditions.
We construct custom-designed assay protocols specifically optimized for your target candidates, whether you are evaluating small molecules, research-grade antibodies, chimeric antigen receptor cell platforms, or highly advanced biomimetic drug delivery systems.
Our platforms utilize pristine primary cell populations, including high-yield human CD14+ monocyte isolations sourced from diverse donor cohorts and highly viable murine bone marrow progenitors differentiated under optimized, serum-free conditions.
Our proprietary PMA-attenuation methods for human THP-1 and U937 cell lines minimize background activation and baseline cytokine noise, preserving the cells' dynamic response range to ensure sensitive, reproducible target evaluation.
We evaluate key inflammatory and resolution checkpoints in cardiac systems, modeling plaque destabilization, foam cell pathobiology, and efferocytic clearance mechanics under physiological conditions to de-risk your cardiovascular candidate profiling.
Learn More →This service quantifies intracellular replication and host defense kinetics within specialized primary or iPSC-derived macrophages, evaluating candidate therapies designed to accelerate phagosome-lysosome fusion and targeted pathogen clearance.
Learn More →We model chronic tissue scarring using multicellular co-cultures and microfluidic organ-on-chip devices to analyze extracellular matrix remodeling, collagen deposition, and macrophage-mediated resolution metrics for anti-fibrotic discovery.
Learn More →This system quantifies the regenerative capacity of M2-polarized macrophages, analyzing how novel agents induce neovascularization, accelerate vessel branching, and interface with endogenous progenitors to drive dermal, osteoid, or neural repair.
Learn More →Evaluating your research candidates under conditions that closely reflect human cellular biology. We avoid non-translatable animal or legacy systems to ensure your results mirror native physiological settings.
Utilizing our advanced, proprietary cell-conditioning methods to stabilize primary and iPSC-derived macrophage phenotypes, preserving their functional plasticity and preventing background activation bias during your screening.
Employing rigorous analytical gating protocols to eliminate false positives in clearance assays. Our doublet exclusion methods guarantee the accurate quantification of true intracellular target engulfment.
Removing experimental ambiguity from your innate immunobiology profiling. We provide validated, reproducible datasets that empower your team to make confident, data-driven decisions for early-stage development.
Get a Quote Today to design high-resolution, translationally validated assays tailored to your specific discovery targets.
Can we customize the donor cohort sizes and genetic backgrounds for primary human macrophage research models?
Yes, absolutely. We source our primary cells from highly characterized, diverse healthy donor cohorts. We can select and stratify donors based on specific age range, gender, or metabolic profiles to match your research targets. Contact our scientific team to discuss your cohort stratification needs.
How does Creative Biolabs distinguish between true target engulfment and simple cell adhesion in phagocytosis assays?
Standard assays often struggle with false positives caused by target cells sticking to the macrophage membrane. We utilize high-resolution flow cytometry paired with rigorous forward scatter/side scatter doublet exclusion and confocal fluorescent imaging to confirm complete cellular internalization, ensuring only authentic engulfment is quantified.
By employing Creative Biolabs' flow cytometry protocols with rigorous doublet exclusion, we successfully eliminated spurious cell-adhesion signals, thereby introducing high resolution to our checkpoint inhibitor assessment and optimizing target validation.
Learn More →We evaluate ligand-receptor checkpoint interactions using high-resolution in vitro binding assays and co-culture platforms, tracking the modulation of pathways like CD47/SIRPα to verify target-specific immunobiology during preclinical discovery.
Learn More →By merging extensive immunological expertise with high-precision microfluidic systems and multiparametric analytical platforms, Creative Biolabs characterizes myeloid biology with rigorous accuracy. The application of biomimetic microenvironments and automated screening arrays yields highly predictive datasets, enabling research teams to define target engagement, confirm critical program milestones, and substantiate the valuation of preclinical candidates.
Ready to accelerate your drug discovery timeline and secure publication-grade datasets? Let’s partner to design a customized study tailored to your exact target specifications, chosen species profiles, and screening scale, please contact us.
Reference